SCHEMBL6174636

SCHEMBL6174636

CC(c1ccncc1C(=O)Nc1ccccc1)C1(C(C)c2ccncc2C(=O)Nc2ccccc2)NC(=O)N(c2ccc(OC(F)(F)F)cc2)C1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
NPC1 O15118 4/20 0.41
RAB9A P51151 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
NR3C1 P04150 1/20 0.40
KDR P35968 3/20 0.40
CYP3A4 P08684 1/20 0.40
GAA P10253 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
ABL1 P00519 5/20 0.40
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
FLT1 P17948 2/20 0.38
NAMPT P43490 1/20 0.38
OPRM1 P35372 1/20 0.38
KCNH2 Q12809 1/20 0.38
THRB P10828 1/20 0.38
MEN1 O00255 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6172522 0.88 CYP3A4 (0.40) ALDH1A1NPC1RAB9AL3MBTL1CYP3A4
SCHEMBL6173899 0.87 ALDH1A1 (0.39) ALDH1A1NPC1RAB9AL3MBTL1CYP3A4
SCHEMBL6172103 0.86 RXFP1 (0.42) ALDH1A1L3MBTL1CYP3A4GAACYP2C9
SCHEMBL6175486 0.85 CYP3A4 (0.40) ALDH1A1NPC1RAB9AL3MBTL1KDR
SCHEMBL6174515 0.85 ALDH1A1 (0.45) ALDH1A1CYP3A4GAACYP2C9CYP2C19
SCHEMBL6172844 0.85 CYP3A4 (0.40) ALDH1A1NPC1RAB9AL3MBTL1KDR
SCHEMBL6174469 0.84 TDP1 (0.42) ALDH1A1NR3C1KDRCYP3A4GAA
SCHEMBL6174774 0.83 SLC5A1 (0.40) ALDH1A1L3MBTL1CYP3A4GAACYP2C9
SCHEMBL6175907 0.83 ALDH1A1 (0.39) ALDH1A1NPC1RAB9AKDRCYP3A4
SCHEMBL6173479 0.82 ALDH1A1 (0.44) ALDH1A1CYP3A4GAACYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed